Skip to main content

50 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights and shares making of the share capital - november 2012

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Forcyl® - a booming brand

Lure (France), November 14, 2012 – Vétoquinol receives a new indication for its Forcyl® product, designed for cattle, and a new market authorization for Forcyl® Swine for pigs.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2012

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Sales momentum continues in Q3

Vétoquinol posted sales of €220.9 million for the first 9 months of 2012, up 6.2% compared to the same period last year.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - September2012

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Vétoquinol purchases ORSCO laboratoire vétérinaire

Lure (France), September 25, 2012 – Vétoquinol announces the purchase of the entire equity of Orsco Laboratoire Vétérinaire.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2012

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Vétoquinol returns to growth

Lure (France), 29 August 2012 – At its 29 August 2012 meeting, the Vétoquinol S.A. board of directors reviewed the Group results and approved the financial statements for the first six months of 2012.

Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - July 2012

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Voting rights

Solid first half 2012 Sales

First half 2012 sales reached €146.8 million, up 5.1% over first half 2011.

Public releases